High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status-Reference-Cited by-同舟云学术

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status

Published:2016-10-25 Issue:1 Volume:66 Page:51-61
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Veluchamy John P.,Heeren A. Marijne,Spanholtz Jan,van Eendenburg Jaap D. H.,Heideman Daniëlle A. M.,Kenter Gemma G.,Verheul Henk M.,van der Vliet Hans J.,Jordanova Ekaterina S.,de Gruijl Tanja D.

Funder

FP7 Marie Curie NATURIMMUN network

KWF Kankerbestrijding

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-016-1919-1.pdf

Reference50 articles.

1. Trottier H, Franco EL (2006) The epidemiology of genital human papillomavirus infection. Vaccine 24(Suppl 1):S1–15

2. Woodman CB, Collins SI, Young LS (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7:11–22

3. Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ (2014) Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer 14:395–405

4. Zagouri F, Sergentanis TN, Chrysikos D, Filipits M, Bartsch R (2012) Molecularly targeted therapies in cervical cancer: a systematic review. Gynecol Oncol 126:291–303

5. Diaz-Padilla I, Monk BJ, Mackay HJ, Oaknin A (2013) Treatment of metastatic cervical cancer: future directions involving targeted agents. Crit Rev Oncol Hematol 85:303–314

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Natural Killer Cells Differentiated from Various Pluripotent Stem Cells;International Journal of Molecular Sciences;2024-07-27

2. Advancing Immunotherapies for HPV-Related Cancers: Exploring Novel Vaccine Strategies and the Influence of Tumor Microenvironment;Vaccines;2023-08-11

3. NK cell-derived exosomes enhance the anti-tumor effects against ovarian cancer by delivering cisplatin and reactivating NK cell functions;Frontiers in Immunology;2023-01-19

4. Towards Novel Gene and Cell Therapy Approaches for Cervical Cancer;Cancers;2022-12-30

5. Chasing Uterine Cancer with NK Cell-Based Immunotherapies;Future Pharmacology;2022-12-09